Trade AirSculpt Technologies, Inc. - AIRS CFD

Trading Conditions

• Spread: 0.12
• Long position overnight feeLong position overnight feeMargin. Your investmentUS$1,000.00Overnight feeCharges from full value of position-0.026179 %(-US$1.05)Trade size with leverage ~ US$5,000.00Short position overnight fee ~ US$4,000.00Go to platform: -0.026179%
• Short position overnight feeShort position overnight feeMargin. Your investmentUS$1,000.00Overnight feeCharges from full value of position0.003957 %(US$0.16)Trade size with leverage ~ US$5,000.00Short position overnight fee ~ US$4,000.00Go to platform: 0.003957%
• Overnight fee time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 20
• Stock exchange: United States of America
• Commission on trade: 0%

• Margin. Your investment: US$1,000.00
• Overnight feeCharges from full value of position: -0.026179 %
  (-US$1.05)

• Margin. Your investment: US$1,000.00
• Overnight feeCharges from full value of position: 0.003957 %
  (US$0.16)

Key Stats

• Prev. Close: 5.44
• Open: 5.38
• 1-Year Change: 10.47%
• Day's Range: 5.38 - 5.5

AirSculpt Technologies, Inc. Company profile

About Airsculpt Technologies Inc

AirSculpt Technologies, Inc. is a holding company. The Company's activities are conducted through the Professional Associations and its wholly owned subsidiaries, which owns and operates the non-clinical assets and provide management services. It offers patients a range of customized body contouring procedures, including fat removal and fat transfer. The Company also offers fat transfer procedures that uses the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its fat transfer procedures include Power Brazilian Butt Lift (BBL), a Brazilian butt lift procedure; Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. The Company also leverages AirSculpt TV, which allows viewers into procedure rooms to watch its surgeons use AirSculpt body contouring procedure. It operates in approximately 16 centers across 13 states.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Airsculpt Technologies Inc revenues increased from $62.8M to $133.3M. Net income increased 39% to $10.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Selling, general and administrative - Ba increase of 88% to $43.6M (expense), Stock-based Compensation in SGA increase from $325K to $7.2M (expense).